CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+39.83%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.04B
AUM Growth
+$1.04B
(+47%)
Cap. Flow
+$153M
Cap. Flow
% of AUM
14.71%
Top 10 Holdings %
Top 10 Hldgs %
79.18%
Holding
32
New
10
Increased
5
Reduced
4
Closed
9
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$78.6M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$67.1M |
| 3 |
AKRX
Akorn, Inc.
AKRX
|
$60M |
| 4 |
United Therapeutics
UTHR
|
$47.2M |
| 5 |
Pediatrix Medical
MD
|
$43.7M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$76.6M |
| 2 |
Assertio
ASRT
|
$44.6M |
| 3 |
Penumbra
PEN
|
$40.7M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$25.9M |
| 5 |
Orthofix Medical
OFIX
|
$25.2M |
Sector Composition
| 1 | Healthcare | 92.73% |
| 2 | Financials | 1.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
| $127M | 12.25% | 3,531,487 +595,000 | +20% | +$21.4M |
|
|
ARIA
2
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $119M | 11.46% | 8,695,742 -150,000 | -2% | -$2.05M |
|
|
MNK
3
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $109M | 10.48% | 1,560,157 | – | – |
|
|
4
United Therapeutics
UTHR
$13.8B
| $96.7M | 9.31% | 818,700 +400,000 | +96% | +$47.2M |
|
|
AMRN
5
Amarin Corp
AMRN
$311M
| $78.6M | 7.57% | +24,652,380 | New | +$78.6M |
|
6
Travere Therapeutics
TVTX
$1.56B
| $69M | 6.65% | 3,084,947 +385,000 | +14% | +$8.62M |
|
|
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $67.1M | 6.45% | +3,698,903 | New | +$67.1M |
|
|
AKRX
8
DELISTED
Akorn, Inc.
AKRX
| $60M | 5.77% | +2,200,000 | New | +$60M |
|
|
9
Ironwood Pharmaceuticals
IRWD
$214M
| $52.3M | 5.04% | 3,296,539 -1,632,600 | -33% | -$25.9M |
|
|
10
Pediatrix Medical
MD
$1.5B
| $43.7M | 4.21% | +660,000 | New | +$43.7M |
|
11
ANI Pharmaceuticals
ANIP
$2.03B
| $43.3M | 4.17% | 653,258 -164,198 | -20% | -$10.9M |
|
12
Globus Medical
GMED
$8.27B
| $42M | 4.04% | +1,860,000 | New | +$42M |
|
|
MACK
13
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $37.8M | 3.64% | +5,950,225 | New | +$37.8M |
|
|
14
Orthofix Medical
OFIX
$592M
| $27.1M | 2.61% | 634,496 -590,000 | -48% | -$25.2M |
|
15
Myriad Genetics
MYGN
$593M
| $17.5M | 1.68% | +850,000 | New | +$17.5M |
|
16
eHealth
EHTH
$118M
| $12.9M | 1.25% | +1,154,711 | New | +$12.9M |
|
17
HealthStream
HSTM
$832M
| $9.41M | 0.91% | +340,847 | New | +$9.41M |
|
18
ADMA Biologics
ADMA
$4.12B
| $9.22M | 0.89% | 1,273,933 | – | – |
|
19
Vericel Corp
VCEL
$1.83B
| $6.25M | 0.6% | 2,232,940 | – | – |
|
20
AtriCure
ATRC
$1.84B
| $3.67M | 0.35% | +231,926 | New | +$3.67M |
|
|
BIOL
21
DELISTED
Biolase, Inc.
BIOL
| $3.13M | 0.3% | 1,790,992 +533,700 | +42% | +$934K |
|
|
SPNE
22
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $2.66M | 0.26% | 262,934 +7,600 | +3% | +$76.8K |
|
23
Veracyte
VCYT
$2.39B
| $1.26M | 0.12% | 165,825 | – | – |
|
|
24
Assertio
ASRT
$80.4M
| – | – | -2,275,300 | Closed | -$44.6M |
|
25
Axogen
AXGN
$743M
| – | – | -526,351 | Closed | -$3.62M |
|